The nurse is discussing the current use of genetic testing and tamoxifen with a client who has breast cancer. Which information should the nurse include in this discussion?
Select all that apply.
Note: Credit will be given only if all correct choices and no incorrect choices are selected.
◦ The United States Agency of Healthcare Research and Quality recommends genetic testing for clients starting tamoxifen.
◦ Insurance providers in the United States do not support the use of CYP2D6 testing prior to prescribing tamoxifen.
◦ Dutch researchers support CYP2D6 testing prior to prescribing tamoxifen.
◦ Some European groups recommend using medications other than tamoxifen for women whose CYP2D6 testing reveals intermediate metabolizer status.
◦ Recommendations from across the globe vary as to the benefit of genetic testing prior to prescribing tamoxifen.
Genetic Determinants Borne by Plasmids
Client receiving hemodialysis.
Gram Positive Testing
Sensitivity Testing
The genetic code (as written in RNA)
Genetic polymorphism for foraging behavior in fruit fly larvae